Science Explorer Back to mapMap
Discussion
Researcher · Eisenhower Medical Center · United States

Luke P. Dreisbach

Luke P. Dreisbach publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Chronic Lymphocytic Leukemia Research and Cancer Immunotherapy and Biomarkers.

OpenAlex
World rank
#2,002,613
of 7,710,434 ranked researchers
Rank in United States
#607,943
of 1,627,098
Works
33
Citations
2k
Citations per work
59.5
h-index
12
i10-index 13Top 48% in Oncology
Luke P. Dreisbach

What does Luke P. Dreisbach research?

Luke P. Dreisbach's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (9%).

Health Sciences: 20 works · 61.2% of their workMedicine: 20 works · 61.2% of their workOncology: 9 works · 26.5% of their workPulmonary and Respiratory Medicine: 5 works · 14.3% of their workHematology: 3 works · 9.2% of their workGenetics: 2 works · 7.1% of their workPublic Health, Environmental and Occupational Health: 1 works · 4.1% of their workEverything else: 10 works · 29.6% of their workLife Sciences: 3 works · 9.2% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 9.2% of their workMolecular Biology: 3 works · 9.2% of their workTHEIR WORKLuke P. Dreisbach33works
Life Sciences9%Health Sciences61%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2061.2%
  2. Everything else1029.6%
    1. Biochemistry, Genetics and Molecular Biology39.2%
  1. 1Oncology26% of their works
  2. 2Pulmonary and Respiratory Medicine14% of their works
  3. 3Molecular Biology9% of their works
  4. 4Hematology9% of their works
  5. 5Genetics7% of their works
  6. 6Public Health, Environmental and Occupational Health4% of their works

Research topics

Which keywords describe Luke P. Dreisbach's research?

The keywords of their largest research topics: Prognostic Factors, Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, Chronic Lymphocytic Leukemia and Genomic Aberrations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Prognostic Factors143 topics
  2. Clinical Trials122 topics
  3. Targeted Therapy122 topics
  4. Chemotherapy92 topics
  5. ALK Inhibitors71 topic
  6. EGFR Mutations71 topic
  7. Chronic Lymphocytic Leukemia61 topic
  8. Genomic Aberrations61 topic
  9. Genomic Profiles51 topic
  10. Immune Checkpoint Blockade51 topic
  11. PD-1 and PD-L151 topic
  12. Small-Cell Lung Cancer51 topic
  13. Cetuximab41 topic
  14. KRAS Mutations41 topic
  15. AML31 topic
  16. Acute Myeloid Leukemia31 topic
  17. BRAF gene31 topic
  18. Catheter-Related Infections31 topic
  19. Central Venous Catheterization31 topic
  20. MAP Kinase31 topic

Where does Luke P. Dreisbach work?

Luke P. Dreisbach's main affiliation in the publication record is Eisenhower Medical Center, United States.

How many publications and citations does Luke P. Dreisbach have?

OpenAlex counts 33 works and 1,964 citations for Luke P. Dreisbach, an h-index of 12, ranking #2,002,613 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Luke P. Dreisbach. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.